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Hepatitis C virus NS5B protein is an RNA-dependent RNA polymerase. To investigate the properties and function of this
protein, we have expressed the NS5B protein in insect and mammalian cells. NS5B was found to be present as fine speckles
in the cytoplasm, particularly concentrated in the perinuclear region, suggesting its association with the nuclear membrane,
the endoplasmic reticulum, or the Golgi complex. This conclusion was supported by the biochemical demonstration that
NS5B was associated with the membranes in the cells. Furthermore, it was shown that NS5B protein is a phosphoprotein.
These properties may be related to its function as an RNA polymerase. q 1997 Academic Press
INTRODUCTION Most of the biochemical studies so far have been fo-
cused on the viral structural proteins and nonstructural
Hepatitis C virus (HCV) is the major etiologic agent of protein NS3, which is a serine proteinase. Among the
blood-borne, non-A, non-B hepatitis (Choo et al., 1989; other nonstructural proteins, NS4 is a cofactor for the
Kuo et al., 1989), which often leads to hepatocellular NS3 proteinase (Failla et al., 1994; Lin and Rice, 1995),
carcinoma (Saito et al., 1990; Shimotohno, 1993). HCV and NS5B has RNA-dependent RNA polymerase (RDRP)
contains a single-stranded, positive-sense RNA genome activity, which has been detected in vitro but so far lacks
of approximately 9400 nucleotides, which shares se- demonstrable specificity in its template requirement (Beh-
quence homology with flaviviruses and pestiviruses rens et al., 1996). Because this activity is likely important
(Choo et al., 1989; Inchauspe et al., 1991; Kato et al., for viral replication, we are particularly interested in un-
1990; Miller and Purcell, 1990; Takamizawa et al., 1991). derstanding the biochemical properties of NS5B. In this
The viral genome has a highly conserved 5*-untranslated study, using both mammalian and baculovirus expres-
region (Han et al., 1991) and encodes a single polyprotein sion systems, we found that NS5B is localized in the
of 3010 amino acids, which is proteolytically processed cytoplasm, preferentially in the perinuclear region, and
into multiple viral proteins (Grakoui et al., 1993c; Hijikata associated with the membrane. Furthermore, we found
et al., 1991; Lin et al., 1994; Manabe et al., 1994). These that it is a phosphoprotein. These properties may be
include core (C), envelope (E1, E2), proteinase, helicase, significant in HCV RNA synthesis.
replicase, and other functionally unidentified nonstructu-
ral proteins. The viral structural proteins are cleaved by
MATERIALS AND METHODSa host signal peptidase (Han et al., 1991; Hijikata et a.,
1991; Matsuura et al., 1994), and the nonstructural pro- Expression of NS5B in insect cells by recombinant
teins (NS) are processed by viral proteinases (Grakoui baculovirus
et al., 1993a,b; Hahm et al., 1993; Tomei et al., 1993).
A cDNA corresponding to the NS5B-coding region ofStudies of the biochemical properties and functional
the Korean isolate of the HCV genome (genotype Ib) (Choroles of HCV gene products have been hampered by the
et al., 1993) was amplified by polymerase chain reactionlow level of protein expression in virus-infected tissues
(PCR) using Taq DNA polymerase (Boehringer Mann-and the lack of an efficient cell culture system in vitro.
heim). PCR primers were designed to create a BamHI
site at both ends, plus an artificial initiation codon (ATG).
1 To whom correspondence and reprint requests should be ad- The PCR product was digested by BamHI and inserted
dressed at Howard Hughes Medical Institute, Department of Molecular
into the BamHI sites of a baculovirus transfer vector,Microbiology and Immunology, University of Southern California School
pVL941 (Hwang et al., 1992). After confirmation of theof Medicine, 2011 Zonal Avenue, HMR-401, Los Angeles, California
90033-1054. Fax: (213) 342-9555. E-mail: michlai@hsc.usc.edu. sequence by the dideoxynucleotide chain termination se-
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quencing method (Sanger et al., 1977), both wild-type were purchased from SamYook Lab Animal Center. Each
animal was immunized with 100 mg of NS5B protein inAutographa californica nuclear polyhedrosis virus
(AcNPV) DNA and recombinant transfer plasmid DNA complete Freund’s adjuvant by multiple subcutaneous
injections. Four booster injections were performed at 2-were cotransfected into Spodoptera frugiperda (Sf9)
cells, and recombinant baculovirus was selected and to 3-week intervals with 70 mg of NS5B protein in incom-
plete Freund’s adjuvant per injection. Animals were anes-amplified as described previously (Hwang et al., 1992).
The Sf9 insect cells were cultured in Grace’s insect tis- thetized and whole sera were collected by cardiac punc-
ture.sue culture medium (GIBCO BRL) supplemented with
10% fetal calf serum (FCS). The AcNPV and recombinant The rabbit antiserum was used at 1/2000 dilution for
immunofluorescence or immunoprecipitation.baculoviruses were grown and assayed in Sf9 cells as
previously described (Hwang and Lai, 1993; Hwang et Human serum used in this study was obtained from a
Korean chronic HCV (genotype Ib) patient. The antibodyal., 1992). For expression of NS5B protein in insect cells,
monolayers of Sf9 cells were infected with recombinant was of IgG class. The antibody was used at 1:250 dilution
for immunoblotting and immunoprecipitation.baculoviruses at a multiplicity of infection (m.o.i.) of 10
and incubated at 277. Cell lysates prepared at various
time points after infection were analyzed by electrophore- Immunoblot analysis
sis on a 10% SDS–PAGE gel and stained with Coomassie
brilliant blue. Proteins were separated by electrophoresis in 10%
polyacrylamide gel containing 0.5% SDS and transferred
Expression of NS5B in mammalian cells to a nitrocellulose membrane (Millipore) by electrotran-
sfer for 1 hr at 47. The membrane was incubated in TBS
To construct the mammalian expression vector, the
buffer (20 mM Tris–HCl, 500 mM NaCl, pH 7.5) con-
cDNA for the NS5B-encoding region was amplified by
taining 3% gelatin for 1 hr at room temperature and
PCR and cloned into the BamHI site of the plasmid
washed twice with TTBS buffer [0.05% Tween 20 (v/v) in
pcDNA3 (Invitrogen) under the control of both a cytomeg-
TBS]. The membrane was then incubated overnight at 47
alovirus (CMV) immediate early promoter and a T7 pro-
with either human HCV patient sera or rabbit polyclonal
moter. Construction procedures were similar to those
antibody in TTBS buffer containing 1% gelatin. After
described above for the NS5B-expressing recombinant
washing several times with TTBS, the membrane was
baculovirus. The expression of the NS5B was achieved
further incubated with either alkaline phosphatase-conju-
by two different methods: in the first method, the protein
gated goat anti-human IgG or goat anti-rabbit IgG (Jack-
was expressed from the T7 promoter of the plasmid by
son ImmunoResearch) for 1 hr at room temperature. The
vTF7-3 recombinant vaccinia virus, which expresses T7
bound antibody was visualized by incubating membrane
RNA polymerase (Fuerst et al., 1986). For this purpose,
in the carbonate buffer (100 mM NaHCO3 , 1 mM MgCl2 ,COS 7 cells (Gluzman, 1981) were grown in Dulbecco’s
pH 9.8) containing 5-bromo-4-chloro-3-indolyl phosphate,
modified Eagle media (DMEM) supplemented with 5%
p-toluidine salt (BCIP)/p-nitroblue tetrazolium chloride
FCS in a 60-mm-diameter dish and infected with vTF7-3
(NBT) (Bio-Rad) reagents.
at a multiplicity of infection of 5. At 2 hr postinfection, the
infected cells were transfected with either pcDNA3 or
ImmunofluorescencepcDNA3-NS5B plasmid (5 mg each) by using DOTAP
(Boehringer Mannheim) as described previously (Hwang
COS 7 cells grown on chamber slides (Nunc, Inc., IL)
and Lai, 1994). Cells were harvested after incubation for
were either mock-transfected or transfected with
12 hr at 377 and analyzed by immunoblotting. In the sec-
pcDNA3-NS5B recombinant plasmid DNA as described
ond method, NS5B was expressed from the CMV pro-
above. At 40 hr posttransfection, slides were washed in
moter of the recombinant plasmid. For this purpose, the
phosphate-buffered saline (PBS) and fixed in cold ace-
same transfection protocol was used, but in the absence
tone for 5 min. Cells were rinsed in PBS twice and incu-
of vaccinia virus infection. Cells were used for immuno-
bated with either preimmune serum or rabbit anti-NS5B
fluorescence analysis at 48 hr posttransfection.
antibody for 1 hr at 377. After washing in PBS, cells were
further incubated at 377 for 30 min with rhodamine-conju-Preparation of rabbit polyclonal antibody against
gated goat anti-rabbit IgG (American Qualex). Cells wereNS5B and human HCV patient sera
washed several times in PBS and then examined using
a Zeiss confocal microscope.Recombinant baculovirus-infected cell lysates were
separated by SDS–PAGE (Fig. 1) and the NS5B protein For Sf9 cells, a monolayer of insect cells infected with
the recombinant baculovirus was processed at 36 hrband was carefully excised and purified by using a Bio-
Rad electroeluter (Model 422) as previously described postinfection as described above for COS 7 cells, except
that either normal human serum or HCV patient serum(Hwang et al., 1992). Female New Zealand White rabbits
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was used as the primary antibody and goat anti-human
IgG (American Qualex) as a secondary antibody.
Membrane flotation analysis
This analysis was performed according to the pre-
viously described procedure (Matsumoto et al., 1996;
Sanderson et al., 1994). Briefly, insect cells infected with
recombinant baculoviruses were harvested at Day 3
postinfection, lysed in 0.5 ml hypotonic buffer (10 mM
Tris–HCl, pH 7.5, 10 mM KCl, 5 mM MgCl2), and further
disrupted by passage through a 25-gauge hypodermic
needle 10–20 times. Cell lysates were centrifuged at
1500 rpm for 10 min in a microfuge, and the supernatant
was carefully collected. Approximately 0.5 ml of superna-
tant was dispersed into 3.0 ml of 72% sucrose in low-
salt buffer (LSB, 50 mM Tris–HCl, pH 7.5, 25 mM KCl, 5
FIG. 1. Expression of NS5B in insect cells. Wild-type (WT) or recombi-
mM MgCl2) and overlaid with 4 ml of 55% sucrose in nant baculovirus (5B)-infected Sf9 cells were harvested at 3 days post-
LSB and 1.5 ml of 10% sucrose in LSB. Gradients were infection. Proteins were separated by electrophoresis in a 10% poly-
acrylamide gel containing SDS and stained with Coomassie brilliantcentrifuged in a Beckman SW41TI rotor at 47 for 14 hr at
blue. M, molecular mass marker (in kDa). C, uninfected cells. The arrow38,000 rpm. Fractions (1 ml) were then collected from
on the right indicates the NS5B protein.the top of the gradient. Each fraction was diluted in 4 ml
of LSB and recentrifuged in a Beckman SW55TI rotor at
46,000 rpm for 90 min at 47. The resulting pellets were performed with T7 RNA polymerase for 70 min at 377.
analyzed by immunoblotting, using rabbit anti-NS5B anti- Aliquots of the transcribed RNAs were translated in rab-
body and 125I-protein A as previously described (Hwang bit reticulocyte lysate (Promega) for 1 hr at 307C using
and Lai, 1993). [35S]methionine.
Radiolabeling and immunoprecipitation
RESULTS AND DISCUSSION
Sf9 cells infected with recombinant baculoviruses
Expression and characterization of NS5B in insectwere first incubated with methionine-free Grace’s insect
and mammalian cellscell medium (GIBCO BRL) for 1 hr at 2 days postinfection
and labeled with 100 mCi/ml of [35S]methionine and cys- To study the biochemical properties of NS5B, we first
teine (NEN) for 4 hr. The cells were washed twice in constructed a recombinant baculovirus containing the
PBS, lysed in RIPA buffer [1% Nonidet P-40, 1% sodium HCV NS5B-coding sequence under the control of the
deoxycholate, 150 mM NaCl, 50 mM Tris–HCl (pH 8.0), polyhedrin promoter and used it to infect Sf9 cells; pro-
0.1% SDS, 0.1 mM PMSF], and centrifuged at 15,000 g tein expression was analyzed 3 days postinfection. The
for 15 min. Aliquots of cell lysates were incubated with results showed that a major protein species of approxi-
either control sera from a healthy donor or HCV patient mately 64 kDa, which is equivalent to the predicted mo-
sera or rabbit preimmune or anti-NS5B sera for 2 hr at lecular weight of NS5B, was detected in the recombinant
47. The immune complex was further incubated with pro- virus-infected cells, but not in uninfected cells or in wild-
tein A–Sepharose for 1 hr and washed five times in RIPA type baculovirus-infected cells (Fig. 1). The nature of this
buffer by centrifugation in a microfuge. The immunopre- protein was confirmed by immunoblotting using sera
cipitates were analyzed as previously described (Hwang from human HCV patients. As shown in Fig. 2A, the pa-
and Lai, 1994). For the analysis of phosphorylation, the tient’s serum detected the 64-kDa protein and two other
recombinant baculovirus-infected Sf9 cells were incu- smaller proteins of 62 and 35 kDa, which are likely the
bated for 1 hr in phosphate-free Grace’s insect cell me- degradation products of NS5B. None of these proteins
dium at 48 hr postinfection and labeled with 300 mCi/ml reacted with sera from normal blood donors (data not
of [32P]orthophosphate (ICN) for 4 hr. Cells were washed shown). No proteins were detected in the wild-type bacu-
in PBS, and proteins were immunoprecipitated as de- lovirus-infected or uninfected cells (Fig. 2A). The 64-kDa
scribed above. protein was then used to prepare a rabbit polyclonal
antibody (see Materials and Methods). The specificity of
In vitro transcription and translation
this rabbit antibody was determined by immunoprecipita-
tion of the in vitro translation product of the NS5B ORFPlasmid DNA (pcDNA3) containing the NS5B-coding
region was linearized with EcoRI, and transcription was in rabbit reticulocyte lysates, which showed that this anti-
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FIG. 2. (A) Characterization of NS5B by immunoblot analysis. Recombinant baculovirus-infected Sf9 cell lysates were separated as shown in
Fig. 1 and electrotransferred to nitrocellulose membrane. The NS5B protein was detected by immunoblotting with an HCV patient serum. (B)
Immunoprecipitation of the in vitro-translated NS5B. NS5B was translated in vitro in rabbit reticulocyte lysate and precipitated with either rabbit
preimmune serum (0) or an antibody raised against the 64-kDa protein from the recombinant baculovirus-infected insect cells (/). IVT, in vitro-
translated products without immunoprecipitation. (C) Comparison of NS5B in insect and mammalian cells. COS 7 cells were infected with recombinant
vaccinia virus expressing T7 polymerase (vTF7-3) (Fuerst et al., 1986) and transfected with plasmid DNA expressing NS5B. Sf9 cells were infected
with the recombinant baculovirus (5B). The proteins were separated by SDS–PAGE and detected by immunoblotting with HCV patient serum. C,
uninfected insect cell lysate. MO, mock-transfected COS 7 cells. The arrow indicates the NS5B.
body precipitated the 64-kDa protein and also several speckles exclusively in the cytoplasm. Most interest-
ingly, these speckles were concentrated primarily insmaller proteins that may represent premature termina-
tion or degradation products (lane 2, Fig. 2B). The preim- the perinuclear regions, particularly associated with
the nuclear membrane (Fig. 3D). This staining was notmune serum did not precipitate any protein (lane 1, Fig.
2B). The NS5B protein expressed in insect cells was then detected when the preimmune rabbit serum was used
(Fig. 3C). Nor did the rabbit serum against NS5B detectcompared with that expressed in mammalian cells using
an expression vector under a T7 promoter in the pres- any staining in the mock-transfected cells (data not
shown). A similar result was obtained when insectence of a recombinant vaccinia virus encoding T7 RNA
polymerase (see Materials and Methods) (Fig. 2C). The cells infected with the NS5B-expressing baculovirus
were examined (data not shown). In this case, thesizes of the proteins expressed in the two different cells
were indistinguishable, suggesting that they have very NS5B was detected by using sera from HCV patients
to avoid possible cross-reaction of the antibody withsimilar posttranslational modifications, if any (Fig. 2C).
However, in COS 7 cells, several additional proteins were other insect cellular proteins. These results indicate
that NS5B is localized predominantly in the perinucleardetected; the nature of these proteins is not clear. No
proteins were detected in the uninfected insect cells or region, suggestive of its association with the nuclear
membrane and the endoplasmic reticulum or Golgiuntransfected COS 7 cells.
complex.
Subcellular localization of the NS5B protein
Membrane association of the NS5B protein
To determine the subcellular localization of NS5B,
an indirect immunofluorescence staining of NS5B was The perinuclear localization of the NS5B protein in
both mammalian and insect cells suggests that it isfirst performed in COS 7 cells transfected with the
NS5B-expressing plasmid (Fig. 3). For this purpose, the associated with the intracellular membranes. To inves-
tigate this possibility, we separated the recombinantNS5B protein was expressed from the CMV promoter in
the absence of recombinant vaccinia virus infection. baculovirus-infected Sf9 cell lysates into membrane
and cytosol fractions, using the membrane flotationThe NS5B was detected by using rabbit polyclonal anti-
body made against the baculovirus-expressed NS5B. method as previously described (Matsumoto et al.,
1996; Sanderson et al., 1994). In this method, the mem-The results showed that NS5B was present as fine
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FIG. 3. Subcellular localization of the NS5B. COS 7 cells transfected with plasmid encoding NS5B were fixed and incubated with either rabbit
anti-NS5B sera (B and D) or rabbit preimmune sera (A and C) as primary antibodies and rhodamine-conjugated goat anti-rabbit IgG as secondary
antibodies. Stained cells were examined using a Zeiss confocal microscope. (A and B) Phase-contrast images. (C and D) Immunofluorescence
staining.
brane-containing materials float to the top of the su- forms of NS5B is not yet clear. These results indicate
that some of the NS5B is associated with the cellularcrose gradient, while the cytosol fractions remain at
the bottom (see Materials and Methods) (Enami and membrane, at least in insect cells.
Enami, 1996; Sanderson et al., 1994). The integral
membrane proteins, such as tumor necrosis factor re- Phosphorylation of the NS5B
ceptor, were found to be localized exclusively in the
membrane fraction (data not shown). The presence of We next examined the possible phosphorylation of
NS5B. We used the baculovirus-expressed NS5B to facili-the NS5B protein in each fraction was determined by
immunoblotting using HCV patients’ sera. As shown in tate detection of protein phosphorylation, since NS5B
was expressed by the recombinant baculovirus at aFig. 4, NS5B protein was found to be localized in both
membrane (fractions 1 – 3) and cytosol fractions (frac- much higher level than by the mammalian expression
vector, and insect cells undergo most of the posttransla-tions 7 – 9). Several NS5B species with slightly different
electrophoretic mobility were detected by HCV pa- tional modifications equivalent to those in mammalian
cells (Miller, 1988). The recombinant baculovirus-infectedtients’ sera. It is noteworthy that, in the membrane frac-
tion (lanes 1 – 3), the larger form of the NS5B was more cells were labeled with either [32P]orthophosphate or
[35S]methionine and cysteine for 3 hr at 48 hr postinfec-abundant than the small form, whereas the reverse
was true for the cytosol fractions (lanes 7 – 9), sug- tion. Metabolically labeled NS5B proteins were immuno-
precipitated with either a rabbit polyclonal antibody orgesting that the large form was enriched in the mem-
brane fractions. The significance of these different HCV patient serum. Figure 5 shows that the NS5B protein
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was labeled by [32P]orthophosphate. No difference in
electrophoretic mobility between 35S- and the 32P-labeled
NS5B was observed. However, the [35S]methionine-la-
beled NS5B appeared to be more diffuse than the 32P-
labeled protein (Fig. 5B), and in some gels, 35S-labeled
NS5B separated into two bands (Fig. 5A), similar to the
results obtained by immunoblotting (Fig. 2). In either
case, only the more slowly migrating form was phosphor-
ylated. No proteins were detected by immunoprecipita-
tion with normal human sera (Fig. 5A) or preimmune
rabbit sera (Fig. 5B). In addition to the 64-kDa protein,
several other [35S]methionine- and 32P-labeled proteins
were coprecipitated, particularly by the rabbit sera.
Whether these proteins represent the degradation prod-
ucts of NS5B and/or cellular proteins associated with
NS5B is not known.
This study thus revealed several new properties of
NS5B, which has previously been demonstrated to have
an RNA-dependent RNA polymerase activity (Behrens et
al., 1996). So far, the possible template specificity of
NS5B for HCV RNA has not been demonstrated. Conceiv-
ably, the polymerase activity and template specificity of
NS5B may be regulated by posttranslational modifica-
tions, such as phosphorylation, of the protein and its
interaction with other viral or cellular proteins. In this
study, we detected a relatively low level of phosphoryla-
tion of NS5B. Considering that there is a total of 117
serine, threonine, and tyrosine residues in the protein,
the phosphorylation level detected was low. This result
suggests that only a few amino acid residues are phos-
phorylated and only a portion of the total protein is phos-
phorylated. This conclusion is consistent with the finding
that the 32P-labeled NS5B species corresponded only FIG. 5. In vivo phosphorylation of NS5B proteins. Insect cells were
infected with the recombinant baculoviruses and labeled metabolicallywith the more slowly migrating species of the [35S]-
with either [35S]methionine and cysteine or [32P]orthophosphate for 4
hr at 2 days postinfection. The NS5B proteins were immunoprecipitated
with (A) HCV patient serum (/) or normal human serum (0) or (B)
rabbit anti-NS5B antibody (/) or preimmune serum (0). The immune-
precipitates were analyzed by SDS–PAGE and autoradiographed. M,
molecular mass marker.
methionine-labeled protein (Fig. 5). Because of the low
level of phosphorylation, we have so far not been able
to determine the phosphoamino acid residues. Neverthe-
less, the level of phosphorylation of the NS5B protein
may be regulated by the physiological conditions of the
infected cells, and phosphorylation of a key amino acid
residue may play a significant role in regulating its activi-
FIG. 4. Membrane flotation analysis of NS5B expressed in insect
ties. Although phosphorylation of NS5B has not beencells. Sf9 cells infected with recombinant baculovirus expressing NS5B
demonstrated so far in mammalian cells because of thewere harvested at 3 days postinfection. Cell lysates were prepared
as described previously (Matsumoto et al., 1996) and subjected to low level of radiolabeling, the finding that the NS5B in
fractionation by equilibrium sucrose gradient centrifugation. One-millili- insect and mammalian cells had indistinguishable sizes
ter fractions were collected from the top of the gradient. Proteins in
suggests that most of the posttranslational modificationseach fraction were analyzed by immunoblotting using HCV patient se-
of the proteins, including phosphorylation, are likely simi-rum. Fractions 1–3, membrane fractions. Fractions 7–9, cytosol frac-
tions. lar between the two cell types.
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Grakoui, A., McCourt, D. W., Wychowski, C., Feinstone, S. M., and Rice,It is interesting that NS5B is localized primarily in the
C. M. (1993a). Characterization of the hepatitis C virus-encoded ser-perinuclear region and associated with cellular mem-
ine proteinase: determination of proteinase-dependent polyprotein
branes. These findings suggest that HCV RNA replication cleavage sites. J. Virol. 67, 2832–2843.
may take place in the membrane fraction in the infected Grakoui, A., McCourt, D. W., Wychowski, C., Feinstone, S. M., and Rice,
C. M. (1993b). A second hepatitis C virus-encoded proteinase. Proc.cells. This is consistent with the findings that RNA syn-
Natl. Acad. Sci. USA 90, 10583–10587.thesis of RNA viruses usually takes place in the mem-
Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M., and Rice, C. M.brane complex (Butterworth et al., 1976; Dennis and
(1993c). Expression and identification of hepatitis C virus polyprotein
Brian, 1982; Lazarus and Barzilai, 1974). The finding that cleavage products. J. Virol. 67, 1385–1395.
the different forms of the NS5B detected in the insect Hahm, B., Han, D. S., Back, S. H., Song, O.-K., Cho, M.-J., Kim, C.-J.,
Shimotohno, K., and Jang, S. K. (1995). NS3-4A of hepatitis C viruscells appear to differ in their relative distribution in the
is a chymotrypsin-like protease. J. Virol. 69, 2534–2539.membrane and cytosol fractions (Fig. 4) may suggest that
Han, J. H., Shyamala, V., Richman, K. H., Brauer, M. J., Irvine, B., Urdea,certain modifications, such as phosphorylation, of NS5B
M. S., Tekamp-Olson, P., Kuo, G., Choo, Q.-L., and Houghton, M.
facilitate its membrane association. Although the precise (1991). Characterization of the terminal regions of hepatitis C viral
relationship between these different forms of the protein RNA: Identification of conserved sequences in the 5* untranslated
region and poly(A) tails at the 3* end. Proc. Natl. Acad. Sci. USA 88,is not yet known, it is interesting to note that it was the
1711–1715.more slowly migrating form which was phosphorylated
Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., and Shimotohno,and was also more enriched in the membrane fractions
K. (1991). Gene mapping of the putative structural region of the hepa-
(Fig. 5). It is not known whether NS5B from HCV of a titis C virus genome by in vitro processing analysis. Proc. Natl. Acad.
different genotype displays different biochemical proper- Sci. USA 88, 5547–5551.
Hijikata, M., Mizushima, H., Akagi, T., Mori, S., Kakiuchi, N., Kato, N.,ties. The posttranslational modifications and membrane
Tanaka, T., Kimura, K., and Shimotohno, K. (1993). Two distinct pro-association of NS5B may play a significant role in the
teinase activities required for the processing of a putative nonstructu-function of HCV polymerase.
ral precursor protein of hepatitis C virus. J. Virol. 67, 4665–4675.
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